Correction: Virus Outbreak-Business Fallout story
|
July 9, 2020 12:03 AM
In a story July 7, 2020, about business-related fallout from the coronavirus pandemic, The Associated Press erroneously reported Regeneron Pharmaceuticals is working on a COVID-19 vaccine candidate. The drug, REGN-COV2, is a double antibody combination being studied for potential treatment and prevention of the disease, not a vaccine.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
